Jones Day is counsel for a European-based company in the lawsuit over contractual rights and obligations.
May 04, 2023 at 03:09 PM
3 minute read
The pharmaceutical company Esperion has retained Gibson, Dunn & Crutcher in a federal lawsuit seeking $300 million from a European pharmaceutical company, claiming that the company failed to fulfill its contractual obligations in connection with a cholesterol medication.
Esperion sued the defendant, Daiichi Sankyo Europe, in Manhattan federal court on March 27 and filed an amended complaint on Thursday, the same day a Gibson Dunn team led by partner Orin Snyder entered appearances in the suit.
Deal Watch: Skadden, Sidley, Slaughter and S&C Lead Big Paper Deal, While Private Funds Grow Massive
Presented by BigVoodoo
The New York Law Journal honors attorneys and judges who have made a remarkable difference in the legal profession in New York.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
Gibson, Dunn & Crutcher offices. Photo: Diego M. Radzinschi/ALM
